BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Oligonucleotide Array Sequence Analysis

Below is an extended Oligonucleotide Array Sequence Analysis research listing. Click here to return to the Oligonucleotide Array Sequence Analysis main in depth entry.

Recent Publications on Oligonucleotide Array Sequence Analysis:

Genetic clustering of clear cell renal cell carcinoma based on array-comparative genomic hybridization: its association with DNA methylation alteration and patient outcome.
PURPOSE: The aim of this study was to clarify genetic and epigenetic...
Direct Link
4th October, 2008
Pathology Division, National Cancer Center Research Institute, Chuo-ku,
Hepatocyte RXRalpha deficiency in matured and aged mice: impact on the expression of cancer-related hepatic genes in a gender-specific manner.
ABSTRACT: BACKGROUND: The occurrence of liver cancer is higher in males...
Direct Link
4th October, 2008
Department of Pharmacology, Toxicology & Therapeutics, University of
Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages.
BACKGROUND: The cause of corticosteroid-resistant (CR) asthma is unknown....
Direct Link
2nd October, 2008
Department of Pediatrics, National Jewish Health, Denver, CO 80206, USA.
A microRNA DNA methylation signature for human cancer metastasis.
MicroRNAs (miRNAs) are small, noncoding RNAs that can contribute to cancer...
Direct Link
1st October, 2008
Cancer Epigenetics Laboratory, Spanish National Cancer Research Center,
A technological update of molecular diagnostics for infectious diseases. 26th September, 2008
Moores Cancer Center, University of California, San Diego, 3855 Health
Comparative genomic hybridization (CGH)--detection of unbalanced genetic aberrations using conventional and micro-array techniques.
This unit presents comparative genomic hybridization (CGH), a genome-wide...
Direct Link
25th September, 2008
Institute of Genetic Medicine, Charite, Berlin, Germany.
Distinct gene expression-defined classes of gastrointestinal stromal tumor.
PURPOSE: The majority of gastrointestinal stromal tumors (GIST) can be...
Direct Link
25th September, 2008
Chemotherapy Division and Cancer Proteomics Project, National Cancer
Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis.
PURPOSE: Substantial evidence implicates insulin-like growth factor-I...
Direct Link
25th September, 2008
Breast Center, Department of Medicine, Baylor College of Medicine,
Genetics: The production line.
PURPOSE: Substantial evidence implicates insulin-like growth factor-I...
Direct Link
24th September, 2008
Insights into the pathobiology of Paracoccidioides brasiliensis from transcriptome analysis--advances and perspectives. 23rd September, 2008
Laboratorio de Biologia Molecular, Departamento de Biologia Celular,
Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.
The 8p11-12 chromosome region is one of the regions most frequently...
Direct Link
19th September, 2008
UMR 144, Centre National de la Recherche Scientifique, Institut Curie,
EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma.
Although p53 is the most frequently mutated gene in cancer, half of human...
Direct Link
19th September, 2008
Children's Cancer Research Institute, St. Anna Kinderkrebsforschung,
PTH mutation with primary hyperparathyroidism and undetectable intact PTH.
BACKGROUND: Turner syndrome (TS) is the most common sex chromosome...
Direct Link
17th September, 2008
Shadow enhancers as a source of evolutionary novelty.
BACKGROUND: The cause of corticosteroid-resistant (CR) asthma is unknown....
Direct Link
10th September, 2008
Department of Molecular and Cell Biology, Division of Genetics, Genomics,
Genetics. Enhancing gene regulation.
BACKGROUND: The cause of corticosteroid-resistant (CR) asthma is unknown....
Direct Link
10th September, 2008
Department of Biology and Institute for Genome Science and Policy, Duke
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional